University of California, San Francisco
35 Medical Center Way, 903A
14 articles with University of California, San Francisco
Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology
Decibel Therapeutics , a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced exclusive license agreements with the University of Florida (UF) and the University of California, San Francisco (UCSF) for an adeno-associated virus (AAV) gene therapy technology designed to restore hearing to individuals with profound, congenital hearing loss c
As we head into cold and flu season, the question arises: Can you get COVID-19 and the flu at the same time?
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
7/10/2020Researchers at the University of California, San Francisco, working with mice, found that by taking blood from mice that exercised regularly and giving it to “couch potato” mice, re-energized the brains of the non-active mice.
Proscia® and UCSF Partner to Deliver Artificial Intelligence Applications That Improve the Accuracy and Speed of Cancer Diagnosis
Proscia ® and UCSF Partner to Deliver Artificial Intelligence Applications That Improve the Accuracy and Speed of Cancer Diagnosis
Data from digital inhalers reveals an increased use of rescue inhalers for asthma symptoms due to short-term exposure to ozone, even below the ozone level set by the EPA
GeoVax Labs, Inc. announced its participation in a collaborative effort led by researchers at the University of California, San Francisco, to develop a combinational therapy aimed at inducing remission in HIV-positive individuals The studies will be conducted with funding from amfAR, The Foundation for AIDS Research..
It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here's a look at some of the stories you may have missed.
ERS Genomics Provides Comment on New Patent Interference With the Broad Institute Relating to Invention of the CRISPR/Cas9 System
ERS Genomics Limited announced that the U.S. Patent and Trademark Office declared a patent interference between 10 separate patent applications owned by the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier, on the one hand, and 13 patents and one application held by the Broad Institute, Harvard University, and the Massachusetts Institute of Technology.
Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it
The University of San Francisco Announces the Launch of the Wicklow AI and Medical Research Initiative
The Data Institute (DI) at the University of San Francisco (USF) is thrilled to announce the launch of the Wicklow AI and Medical Research Initiative (WAMRI), a new research lab focusing on the development of practical applications of AI in medicine.
Saama Technologies, Inc. today announced the addition of six new members to its Clinical Board of Advisors.
TheraNova, LLC, and UCSF Surgical Innovations, an incubator-accelerator for University of California, San Francisco (UCSF) medtech innovators, have announced a partnership that aims to co-develop device technologies for unmet patient needs.